The hexatherapy regimen-driven decrease in tumor burden in the 4T1 tumor model was also associated with increased CD8+ T cell infiltration and proliferation, and decreased CD8+ T cell exhaustion in the tumor (figure 5D–G). The gene discussed is CD8A; the disease is neoplasm.